TrialContemporary oncology (Poznan, Poland)2023
High-dose alectinib for
Rafal Dziadziuszko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
TrialContemporary oncology (Poznan, Poland)2023
Rafal Dziadziuszko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.